Bromma, Sweden

Malin Lindborg

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Hagersten, SE (2012 - 2015)
  • Saltsjo-Boo, SE (2017 - 2019)
  • Bromma, SE (2015 - 2020)
  • Saltsjö-boo, SE (2019 - 2021)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Malin Lindborg in Biotechnology

Introduction

Malin Lindborg, an accomplished inventor based in Bromma, Sweden, has made significant strides in the field of biotechnology. With a portfolio of ten patents, Lindborg's work primarily focuses on the development of engineered polypeptides with therapeutic and diagnostic applications.

Latest Patents

One of Lindborg's latest inventions includes an IL-1R-I binding polypeptide. This engineered polypeptide exhibits a binding affinity for interleukin-1 receptor type-I (IL-1R-I), incorporating a specific binding motif that has potential applications as a therapeutic, prognostic, and diagnostic agent. Additionally, Lindborg has developed polypeptides that bind to human complement C5. These C5 binding polypeptides contain a defined binding motif, allowing them to attach to C5 and serve as a potential treatment for conditions related to this complement component.

Career Highlights

Throughout his career, Malin Lindborg has made notable contributions while working with leading companies in the biotechnology sector, including Affibody AB and Swedish Orphan Biovitrum AB. His innovative mindset and dedication to research have led him to create valuable intellectual property, enriching the medical field with his discoveries.

Collaborations

Lindborg has collaborated with skilled professionals, including Elin Gunneriusson and Joachim Feldwisch. These partnerships have further expanded the scope and impact of his inventions, fostering advancements in therapeutic solutions.

Conclusion

Malin Lindborg's contributions to biotechnology through his patents and collaborations highlight his role as a leading innovator in the field. His engineered polypeptides have the potential to revolutionize therapeutic methods and diagnostic approaches, showcasing the power of innovation in addressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…